2020-12-15T15:14:05-06:00 2020-06-30 GRANT THORNTON LLP 171 N CLARK ST SUITE 200 CHICAGO IL 60601 990 2019-07-01 133039601 Alzheimer's Disease & Related Disorders Association Inc % MICHELLE HELTON CFO ALZ 3123358700 225 N Michigan Ave 17th Floor Chicago IL 606017633 MICHELLE HELTON CFO 3123355771 2020-12-15 true DANIEL ROMANO P00504182 3128560200 2020-12-15 2019 2022-09-23 18:48:47Z RICHARD H HOVLAND 225 N Michigan Ave 17th Fl Chicago IL 606017633 430515973 false X www.alz.org X 1980 DE TO LEAD THE WAY TO END ALZHEIMER'S & ALL OTHER DEMENTIA - BY ACCELERATING GLOBAL RESEARCH, DRIVING RISK REDUCTION & EARLY DETECTION, & MAXIMIZING QUALITY CARE & SUPPORT. 28 28 2689 57172 0 0 365557820 381002937 9518813 7070398 10191501 10240491 4397744 4773180 389665878 403087006 52340877 51905028 0 0 182430888 190548712 1573775 1591733 71853103 150228333 143762020 386573873 387807493 3092005 15279513 377644348 410346682 114820016 134071218 262824332 276275464 X THE ALZHEIMER'S ASSOCIATION IS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN ALZHEIMER CARE, SUPPORT, AND RESEARCH. (MISSION CONTINUED IN SCHEDULE O). false false 213640946 2073307 587791 CONCERN AND AWARENESS - ALZHEIMER'S IS A PROGRESSIVE, DEGENERATIVE AND ULTIMATELY FATAL DISEASE. TOO FEW AMERICANS UNDERSTAND THE CURRENT AND FUTURE ECONOMIC IMPACT OF ALZHEIMER'S. ALREADY MORE THAN 5 MILLION AMERICANS ARE LIVING WITH ALZHEIMER'S AND AS MANY AS 15 MILLION PEOPLE ARE PROVIDING UNPAID CARE AND SUPPORT. AND THIS MASSIVE GROUP IS IN NEED OF INFORMATION AND RESOURCES. THE ALZHEIMER'S ASSOCIATION HAS INVESTED IN EDUCATION CAMPAIGNS AND INITIATIVES TO INCREASE KNOWLEDGE ABOUT ALZHEIMER'S DISEASE AND AWARENESS OF THE ALZHEIMER'S ASSOCIATION COMMUNICATING OUR ROLE AS LEADERS OF THE CAUSE. KEY MESSAGES INCLUDE THE IMPORTANCE OF EARLY DETECTION, RESOURCES FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND THE SOCIETAL IMPACT OF THE DISEASE. MILLIONS OF CONSTITUENTS PARTICIPATED IN OUR PROGRAMS IN LOCAL COMMUNITIES AND ON-LINE. 61740153 43801939 6429352 RESEARCH - THE ALZHEIMER'S ASSOCIATION IS ON THE FOREFRONT OF THE ALZHEIMER'S SCIENTIFIC FIELD, GLOBALLY CONNECTING RESEARCHERS IN THE QUEST TO FIND METHODS OF TREATMENT, PREVENTION AND A CURE. THE ALZHEIMER'S ASSOCIATION IMPLEMENTS AN AGGRESSIVE GLOBAL RESEARCH AND SCIENCE PROGRAM STRATEGICALLY DESIGNED TO ACCELERATE PROGRESS BY FOSTERING INNOVATION, IDENTIFYING AND CLOSING CRITICAL KNOWLEDGE GAPS, DEVELOPING AND DISSEMINATING TOOLS, AND NURTURING SCIENTIFIC TALENT. THE ALZHEIMER'S ASSOCIATION HAS BEEN A CATALYST AND CONVENER FOR 40 YEARS. WHETHER FUNDING INNOVATIVE GRANTS TO HELP FURTHER TREATMENTS AND DISCOVERY, HOSTING THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE* (AAIC*), THE WORLD'S LARGEST GATHERING OF ALZHEIMER'S RESEARCHERS, OR LEADING ENDEAVORS LIKE THE WORLDWIDE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (WW-ADNI) TO ACCELERATE ADVANCES IN IMAGING, THE ALZHEIMER'S ASSOCIATION SEEKS TO FUND AND ADVANCE BEST-IN-CLASS RESEARCH AND WORKS WITH COLLABORATORS AROUND THE GLOBE FROM ALL SECTORS TO HASTEN THIS PROGRESS. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. 4084079 4505 FIELD PROGRAM SUPPORT - APPROXIMATELY 262 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 75 CHAPTERS OF THE ASSOCIATION AND ARE IN COMMUNITIES NATIONWIDE PROVIDING SERVICES TO FAMILIES AND PROFESSIONALS INCLUDING: INFORMATION AND REFERRAL, SUPPORT GROUPS, CARE CONSULTATION, AND EDUCATION AND SAFETY SERVICES. 19612312 6029782 48750 299077490 true true false true false false false false false true true true false false true true false true false false true true false true true false false true true true false false false false false false false false true false false false false true true true true false true 1642 0 true 2689 true true true false false false false true true false false false false true false X 28 28 false false false false false false false true true false true true true true true true true true true true false AL AK AZ CA CT DC FL GA IL KS KY ME MD MA MI MN MS NH NJ NM NY NC OK OR PA RI SC TX UT VA WA WV WI X X X MICHELLE HELTON CFO 3123355183 225 N MICHIGAN AVE 17TH FLOOR Chicago IL 606017633 HARRY JOHNS President & CEO 60.0 0.21 X 1296398 5597 56503 RICHARD HOVLAND COO & ASST. TREAS. 60.0 0.07 X 582435 1004 98888 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 60.0 1.45 X 499053 19422 65985 Maria Carrillo Chief Science Officer 60.0 0.0 X 526607 0 39204 Donna McCullough Chief Development Officer 60.0 0.21 X 465919 2379 67554 Glenda Berry WEST AREA LEADER 60.0 0.0 X 464862 0 53678 KENANN CASSIDY EAST AREA LEADER 60.0 0.0 X 468724 0 45459 Katherine JOANNE PIK Chief Strategy Officer 60.0 0.0 X 407644 0 62291 Michelle Helton Chief Financial Officer 60.0 0.0 X 251894 0 59807 Christine Foh Asst Secy & VP Legal & GC 60.0 0.0 X 265396 0 41138 Alex Tsao Director 5.0 0.0 X 0 0 0 Andrew Dahlkemper Director (BEG. 10/19) 5.0 0.0 X 0 0 0 Anna Catalano SECRETARY AND DIRECTOR 10.0 0.0 X X 0 0 0 Brian Richardson Vice Chair and Director 12.0 0.0 X X 0 0 0 Bruce Baude Director 5.0 0.0 X 0 0 0 Carolyn Tieger Director 5.0 0.0 X 0 0 0 Cecile Perich DIRECTOR 5.0 0.0 X 0 0 0 Cynthia Lemere Director 5.0 0.0 X 0 0 0 David Hunter Director 5.0 0.0 X 0 0 0 David Goltermann Chair and Director 12.0 0.5 X X 0 0 0 Debra Pierson Director 5.0 0.0 X 0 0 0 Derek van Amerongen Director 5.0 0.0 X 0 0 0 Diana Kerwin MD Director (THRU 03/20) 5.0 0.0 X 0 0 0 EILEEN KAMERICK DIRECTOR (BEG. 10/19) 5.0 0.0 X 0 0 0 GEOFF HEREDIA DIRECTOR (BEG. 10/19) 5.0 0.0 X 0 0 0 George Johnson Director 5.0 0.0 X 0 0 0 GEORGE WALZ DIRECTOR (BEG 10/19) 5.0 0.0 X 0 0 0 Helen Brooks Director 5.0 0.0 X 0 0 0 JAY REINSTEIN DIRECTOR (BEG. 10/19) 5.0 0.0 X 0 0 0 James Grossmann Director 5.0 0.0 X 0 0 0 John Tracy Director (THRU 10/19) 5.0 0.0 X 0 0 0 Julia Wallace Treasurer and Director 10.0 0.0 X X 0 0 0 Karen Stevenson Director 5.0 0.0 X 0 0 0 Karyne Jones Director 5.0 0.0 X 0 0 0 Minoo Javanmardian Director 5.0 0.0 X 0 0 0 Pam Montana Director (THRU 10/19) 5.0 0.0 X 0 0 0 Paul Wexler DIRECTOR (THRU 10/19) 5.0 0.0 X 0 0 0 Ralph Nixon MD PhD Director (THRU 10/19) 5.0 0.0 X 0 0 0 Ryan Mundy Director 5.0 0.0 X 0 0 0 Sarah Lorance Director 5.0 0.0 X 0 0 0 Steven Osgood Director 5.0 0.0 X 0 0 0 Thomas Doyle Director 5.0 0.0 X 0 0 0 William Thomas Director 5.0 0.0 X 0 0 0 5228932 28402 590507 266 false true false Hayworth Marketing Media LLC 45 S 7th Street Suite 2400 MINNEAPOLIS MN 55402 ADVERTISING 17929631 World-Wide Printing Distrib Inc 2900 E Apache TULSA OK 74110 Direct Marketing 10842193 Never Without LLC 580 Tanacrest Circle NW ATLANTA GA 30328 ADVERTISING 5325723 Softchoice Corporation 314 W Superior Suite 301 CHICAGO IL 60654 Technology/Equipment 4177542 Navistar Direct Marketing LLC 4612 Navistar Drive FREDERICK MD 21703 direct marketing 2945872 164 707662 568748 22987579 356738948 11407400 381002937 PROGRAM CONFERENCES 611710 4982438 4982438 SAFE RETURN REGISTRATION FEES 611710 694726 694726 JOURNAL 511120 606159 606159 CAREGIVER TRAINING 611710 218327 218327 REGISTRATION/EVENT REVENUE 900099 568748 568748 7070398 8291696 8291696 0 92710 92710 0 0 0 28368972 26366923 53254 2002049 -53254 1948795 1948795 4700628 568748 909953 3790675 3790675 0 0 0 132390 98837 33553 33553 AFFILIATE REVENUE 900099 14103 14103 ALL OTHERR REVENUE 842139 842139 842139 842139 856242 403087006 7070398 15013671 35774846 35774846 1514533 1514533 14615649 14615649 0 2965738 1698184 1102215 165339 0 148355423 109975349 3989219 34390855 21481585 15712397 682442 5086746 17721840 13012012 762703 3947125 24126 15863 8263 0 467786 332876 69372 65538 99325 99325 794033 794033 1591733 1591733 206886 206886 23926518 18356028 1122175 4448315 29059806 25687296 42945 3329565 35828326 24886537 3845919 7095870 1403733 1065359 139962 198412 0 24304846 17537678 3264994 3502174 8661850 6250111 238724 2173015 0 12877804 8318073 154126 4405605 0 0 4515400 2737960 736032 1041408 656161 212851 404716 38594 . 0 . 0 . 0 . 0 959546 579855 15145 364546 387807493 299077490 16876900 71853103 X 16626999 9874893 2628427 4123679 0 0 25013585 34909439 48565644 43782942 7722303 8649680 0 0 0 0 0 0 801900 1143753 6926845 5124112 56596229 33980289 23222095 22615940 229875287 259215453 34689540 34077770 0 0 0 0 827149 827593 377644348 410346682 34975204 31377893 59855867 82909174 5474898 5775797 0 0 0 0 0 0 0 0 0 0 14514047 14008354 114820016 134071218 X 136816114 139186350 126008218 137089114 262824332 276275464 377644348 410346682 X 15279513 3726062 40810 -5595253 X false true X true true true X 158669271 301450526 319867489 361019360 381002937 1522009583 0 0 158669271 301450526 319867489 361019360 381002937 1522009583 0 1522009583 3039352 4882618 6355626 8237819 8384406 30899821 0 7077019 12716507 12152019 8245835 5689260 45880640 1598790044 42704473 0.95198 0.94710 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true true 160134 false true true 6024958 true 2164104 true 113407 false 8462603 false SCHEDULE C, PART II-B, LINE 1A VOLUNTEERS MOST OF THE ASSOCIATION'S ADVOCACY IS THROUGH VOLUNTEERS. ADDITIONALLY THE ASSOCIATION HAS TRAINING TO DEVELOP AND ORGANIZE CHAPTER BASED GRASSROOTS ACTIVITIES. AS ALZHEIMER'S DISEASE AND RELATED DEMENTIAS THREATEN TO BANKRUPT FAMILIES, BUSINESSES AND THE HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR HIGH QUALITY HEALTHCARE AND LONG TERM SERVICES AND SUPPORT FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES. THIS INCLUDES ADVOCACY FOR BETTER CARE FOR PEOPLE AND FAMILIES ALREADY FACING ALZHEIMER'S. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. SCHEDULE C, PART II-B, LINE 1B PAID STAFF OR MANAGEMENT THE ASSOCIATION HAS PAID STAFF WHO ENGAGE ON BEHALF OF THE ASSOCIATION IN PUBLIC POLICY WORK, INCLUDING EDUCATING POLICYMAKERS AND SUPPORTING THE ADVOCACY WORK OF VOLUNTEERS. SCHEDULE C, PART II-B, LINE 1C MEDIA ADVERTISEMENTS MEDIA ADVERTISEMENTS WERE RUN IN WASHINGTON, D.C. FOR KEY ADVOCACY AWARENESS OPPORTUNITIES DURING THE YEAR. SCHEDULE C, PART II-B, LINE 1D MAILING TO MEMBERS, LEGISLATORS OR THE PUBLIC MAILING COSTS TO DISTRIBUTE FACTS AND FIGURES TO LEGISLATORS. THERE WERE NO MAILINGS TO LEGISLATORS THIS YEAR DUE TO THE COVID-19 PANDEMIC. SCHEDULE C, PART II-B, LINE 1E PUBLICATIONS, OR PUBLISHED OR BROADCAST STATEMENTS THE ASSOCIATION DISTRIBUTED FEDERAL AND STATE UPDATES VIA EMAIL AND TEXTS APPROXIMATELY 45 TIMES DURING THE YEAR. 24252597 1490922 1490922 24252597 24043831 208766 1557825 1557825 24252597 24038631 5200 894633 894633 24043831 13717133 10321498 1125281 1125281 24038631 13690883 26250 545968 545968 13717133 0.97900 0.02100 false false 568500 568500 1360785 164217 1196568 12584058 6490986 6093072 10055879 8290156 1765723 32027007 19034930 12992077 22615940 BENEFICIAL INTEREST 33804921 F ASSETS HELD IN TRUST 272849 F 34077770 0 DEFERRED RENT 8483347 GIFT ANNUITY OBLIGATIONS 5525007 14008354 X SCHEDULE D, PART V, LINE 4 INTENDED USES OF ENDOWMENT FUNDS A PORTION OF THE NET ASSETS WITH DONOR RESTRICTIONS ARE RESTRICTED AS INVESTMENTS IN PERPETUITY. THE ASSOCIATION'S ENDOWMENT ONLY CONSISTS OF DONOR-RESTRICTED ENDOWMENT FUNDS. NET ASSETS ASSOCIATED WITH THE ASSOCIATION'S ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OF DONOR-IMPOSED RESTRICTIONS. DONORS RESTRICT THE EARNINGS OF SOME OF THE ASSOCIATIONS ENDOWMENT FUNDS TO FUND THE ASSOCIATION'S RESEARCH PROGRAM. IN ACCORDANCE WITH DONOR STIPULATIONS, THE INCOME GENERATED FROM THESE ASSETS IS RESTRICTED FOR RESEARCH (APPROXIMATELY 57%) OR NOT PURPOSE RESTRICTED (APPROXIMATELY 43%). THE ASSOCIATION ACCOUNTS FOR ENDOWMENT NET ASSETS BY PRESERVING THE FAIR VALUE OF THE ORIGINAL GIFT AS OF THE GIFT DATE OF THE DONOR-RESTRICTED ENDOWMENT FUND ABSENT EXPLICIT DONOR STIPULATIONS TO THE CONTRARY. AS A RESULT, THE ASSOCIATION CLASSIFIES AS PERMANENTLY RESTRICTED NET ASSETS (1) THE ORIGINAL VALUE OF GIFTS DONATED TO THE PERMANENT ENDOWMENT, (2) THE ORIGINAL VALUE OF SUBSEQUENT GIFTS TO THE PERMANENT ENDOWMENT AND (3) ACCUMULATIONS TO THE PERMANENT ENDOWMENT MADE IN ACCORDANCE WITH THE DIRECTION OF THE APPLICABLE DONOR GIFT INSTRUMENT AT THE TIME THE ACCUMULATION IS ADDED TO THE ENDOWMENT FUND. THE ASSOCIATION CONSIDERS THE FOLLOWING FACTORS IN MAKING A DETERMINATION TO APPROPRIATE OR ACCUMULATE DONOR-RESTRICTED ENDOWMENT FUNDS: -THE DURATION AND PRESERVATION OF THE FUND. -THE PURPOSES OF THE ASSOCIATION AND THE DONOR-RESTRICTED ENDOWMENT FUND. -GENERAL ECONOMIC CONDITIONS. -THE POSSIBLE EFFECTS OF INFLATION AND DEFLATION. -THE EXPECTED TOTAL RETURN FROM INCOME AND THE APPRECIATION OF INVESTMENTS. -OTHER RESOURCES OF THE ASSOCIATION. -THE INVESTMENT POLICIES OF THE ASSOCIATION. THE ASSOCIATION HAS ADOPTED AN INVESTMENT POLICY THAT ATTEMPTS TO PROVIDE A PREDICTABLE STREAM OF FUNDING TO PROGRAMS SUPPORTED BY ITS ENDOWMENT WHILE SEEKING TO MAINTAIN THE PURCHASING POWER OF THE ENDOWMENT ASSETS. AS OF JUNE 30, 2020 AND 2019, ENDOWMENT ASSETS ONLY INCLUDE THOSE ASSETS OF DONOR-RESTRICTED FUNDS THAT THE ASSOCIATION MUST HOLD IN PERPETUITY, AS THE ASSOCIATION DOES NOT HAVE ANY BOARD-DESIGNATED ENDOWMENT FUNDS. UNDER THIS POLICY, AS APPROVED BY THE BOARD OF DIRECTORS, THE ENDOWMENT ASSETS ARE INVESTED IN A MANNER THAT IS INTENDED TO PROVIDE ADEQUATE LIQUIDITY, MAXIMIZING RETURNS ON ALL FUNDS INVESTED AND ACHIEVING FULL EMPLOYMENT OF ALL AVAILABLE FUNDS AS EARNING ASSETS. THE ASSOCIATION HAS AN ACTIVE FINANCE COMMITTEE AND INVESTMENT SUB-COMMITTEE THAT MEETS REGULARLY TO ENSURE THAT THE OBJECTIVES OF THE INVESTMENT POLICY ARE MET, AND THAT THE STRATEGIES USED TO MEET THE OBJECTIVES ARE IN ACCORDANCE WITH THE INVESTMENT POLICY. THE ASSOCIATION'S POLICY IS TO APPROPRIATE SPENDING AMOUNTS DEEMED PRUDENT FOR DONOR-RESTRICTED FUNDS. SCHEDULE D, PART X, LINE 2 FIN 48 THE ASSOCIATION AND Alzheimer's Impact Movement (AIM) HAVE RECEIVED FAVORABLE DETERMINATION LETTERS FROM THE INTERNAL REVENUE SERVICE, STATING THAT THEY ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(A) OF THE INTERNAL REVENUE CODE OF 1986 (IRC), AS ORGANIZATIONS DESCRIBED IN SECTIONS 501(C)(3) AND 501(C)(4), RESPECTIVELY, EXCEPT FOR INCOME TAXES PERTAINING TO UNRELATED BUSINESS INCOME. Alzheimer's Impact Movement Political Action Committee (AIMPAC) IS A POLITICAL ACTION COMMITTEE ORGANIZATION EXEMPT FROM FEDERAL TAXES UNDER SECTION 527 OF THE IRC. THE ALZHEIMER'S ASSOCIATION INTERNATIONAL IS A NOT-FOR-PROFIT CANADIAN ENTITY. THE COALITION of New York State Alzheimer's Association Chapters, Inc. IS A NOT-FOR-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE IRC AND HAS NOT BEEN CLASSIFIED AS A PRIVATE FOUNDATION; THEREFORE, NO PROVISION FOR INCOME TAX HAS BEEN MADE IN THE FINANCIAL STATEMENTS. THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ISSUED GUIDANCE THAT REQUIRES TAX EFFECTS FROM UNCERTAIN TAX POSITIONS TO BE RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS ONLY IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. MANAGEMENT HAS DETERMINED THERE ARE NO MATERIAL UNCERTAIN POSITIONS THAT REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS AND, AS SUCH, NO PROVISION FOR INCOME TAXES IS REFLECTED. ADDITIONALLY, THERE ARE NO INTEREST OR PENALTIES RECOGNIZED IN THE CONSOLIDATED STATEMENT OF ACTIVITIES OR STATEMENT OF FINANCIAL POSITION. Schedule D, Part XI, Line 2D RECONCILIATION OF REVENUE CHANGE IN PERPETUAL TRUST ($514,280) CHANGE IN SPLIT INTEREST ($542,513) -------------- TOTAL ($1,056,793) SCHEDULE D, PART XI, LINE 4B RECONCILIATION OF REVENUE COST OF GOODS SOLD ($98,837) ---------- TOTAL ($98,837) SCHEDULE D, PART XII, LINE 2D RECONCILIATION OF EXPENSES COST OF GOODS SOLD $98,837 BAD DEBT EXPENSE $4,538,460 ---------- TOTAL $4,637,297 true Europe (Including Iceland and Greenland) 0 0 Grantmaking 7867687 Middle East and North Africa 0 0 Grantmaking 2724540 East Asia and the Pacific 0 0 Grantmaking 2343913 North America 0 0 Grantmaking 1229539 South America 0 Grantmaking 249970 Sub-Saharan Africa 0 0 Grantmaking 175000 Central America and the Caribbean 0 0 Grantmaking 25000 0 0 0 0 14615649 14615649 North America Program Support 20000 Wire 0 North America Program Support 175000 Wire 0 Europe Program Support 175000 Wire 0 East Asia and the Pacific Program Support 173856 Wire 0 Europe Program Support 174700 Wire 0 Europe Program Support 175000 Wire 0 Europe Program Support 174000 Wire 0 Europe Program Support 50000 Wire 0 North America Program Support 149787 Wire 0 East Asia and the Pacific Program Support 119918 Wire 0 South America Program Support 149970 Wire 0 East Asia and the Pacific Program Support 148103 Wire 0 East Asia and the Pacific Program Support 149710 Wire 0 Europe Program Support 149930 Wire 0 Sub-Saharan Africa Program Support 150000 Wire 0 Europe Program Support 150000 Wire 0 Europe Program Support 43000 Wire 0 Europe Program Support 43000 Wire 0 Europe Program Support 43000 Wire 0 Middle East and North Africa Program Support 25000 Wire 0 Middle East and North Africa Program Support 25000 Wire 0 South America Program Support 25000 Wire 0 South America Program Support 25000 Wire 0 North America Program Support 25000 Wire 0 Europe Program Support 24904 Wire 0 Central America and the Caribbean Program Support 25000 Wire 0 Europe Program Support 24748 Wire 0 Europe Program Support 24908 Wire 0 South America Program Support 25000 Wire 0 South America Program Support 25000 Wire 0 Sub-Saharan Africa Program Support 25000 Wire 0 East Asia and the Pacific Program Support 28125 Wire 0 North America Program Support 859752 Wire 0 Europe Program Support 1546367 Wire 0 East Asia and the Pacific Program Support 1000000 Wire 0 Middle East and North Africa Program Support 2674540 Wire 0 Europe Program Support 1936563 Wire 0 Europe Program Support 992093 Wire 0 Europe Program Support 915654 Wire 0 East Asia and the Pacific Program Support 724201 Wire 0 Europe Program Support 55070 Wire 0 Europe Program Support 12902 Wire 0 Europe Program Support 200000 Wire 0 Europe Program Support 400000 Wire 0 Europe (Including Iceland and Greenland) PROGRAM SUPPORT 556848 WIRE 45 false false true false false false Schedule F, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE U.S. THE OVER-SIGHT OF THE SCIENTIFIC INTEGRITY OF THE ALZHEIMER'S ASSOCIATION NATIONAL AND INTERNATIONAL RESEARCH GRANT PROGRAM (IRGP) IS THREE-FOLD. FIRST, THE ALZHEIMER'S ASSOCIATION VOLUNTARY MEDICAL & SCIENTIFIC ADVISORY GROUP (MSAG), THE ALZHEIMERS ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM (IRGP) COUNCIL, AND ALZHEIMER'S ASSOCIATION MEDICAL & SCIENTIFIC RELATIONS DIVISION, ENSURES PEER REVIEW AND HIGH QUALITY OF FUNDED AWARDS DURING THE GRANT REVIEW PROCESS AND DEVELOPS FOCUSED REQUESTS FOR APPLICATIONS (RFAs) BASED ON IDENTIFIED NEEDS IN THE ALZHEIMERS AND ALL DEMENTIA RESEARCH COMMUNITY. SECOND, THE ALZHEIMER'S ASSOCIATION IS ENGAGED IN A PORTFOLIO ANALYSIS OF SCIENTIFIC AREAS OF INVESTMENT TO MONITOR THE DIVERSITY OF THE GRANTS PORTFOLIO, POTENTIAL GAPS IN RESEARCH FUNDING, AND POTENTIAL OVERLAP OF AREAS FUNDED. THE ANALYSIS INFORMS FUTURE FUNDING DECISIONS, STRATEGIC ACTIVITIES AND AREAS OF FUTURE-RFA FOCUS. THIRD, THERE IS A DETAILED PROCESS ONCE A GRANT IS AWARDED TO MONITOR SCIENTIFIC AND FINANCIAL INTEGRITY. THE ALZHEIMER'S ASSOCIATION MONITORS THE USE OF GRANT FUNDS BOTH INSIDE AND OUTSIDE OF THE UNITED STATES AS FOLLOWS: ALL AWARDEES ARE REQUIRED TO PROVIDE ANNUAL AND IN SOME CASES BI-ANNUAL OR QUARTERLY REPORTING TO THE ALZHEIMER'S ASSOCIATION ON BOTH THE STATUS OF THE RESEARCH PROJECT AND FINANCIAL EXPENDITURES ASSOCIATED WITH THE PROJECT. SEVERAL PROGRAMS ARE LEVERAGED FUNDING OPPORTUNITIES WITH PARTNER ORGANIZATIONS. THESE RESEARCH PROJECTS AND FINANCIAL EXPENDITURE REPORTS ARE SHARED BETWEEN THE PARTNER ORGANIZATION(S). SIXTY DAYS PRIOR TO THE ANNIVERSARY OF THE AWARD START DATE, AN ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER NOTIFIES ALL RESEARCHERS AND ALL DESIGNATED INSTITUTIONAL FINANCIAL OFFICIALS WITH FISCAL RESPONSIBILITY FOR THE AWARD OF THE REQUIRED REPORTS, WHICH INCLUDE AN INTERIM SCIENTIFIC REPORT, INTERIM FINANCIAL REPORT, DOCUMENTATION OF ANY PUBLICATIONS AS A RESULT OF ASSOCIATION FUNDING, AND ANNUAL VERIFICATION OF REQUIRED ETHICAL (ANIMAL AND HUMAN) APPROVALS. THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD CANNOT BE THE PRIMARY INVESTIGATOR OF THE PROJECT. THE ALZHEIMER'S ASSOCIATION PROVIDES A TEMPLATE FOR THE INTERIM SCIENTIFIC REPORT AND A TEMPLATE FOR THE INTERIM FINANCIAL REPORT, BOTH OF WHICH ARE AVAILABLE FOR DOWNLOAD BY THE RESEARCHERS AS WELL AS THE OFFICIAL WITH FISCAL RESPONSIBILITY FOR THE GRANT AT THE AWARDED INSTITUTION AT HTTPS://PROPOSALCENTRAL.COM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WITH FISCAL RESPONSIBILITY, AND ALL REPORTS MUST BE UPLOADED BY THE AWARD RECIPIENT TO PROPOSALCENTRAL. AFTER RECEIPT, ALL FINANCIAL REPORTS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER FOR ACCURACY AND CONSISTENCY WITH THE AGREED UPON BUDGET. ANY SIGNIFICANT VARIANCE (MORE THAN 10% DIFFERENCE) IN EXPENDITURES TO THE APPROVED BUDGET ALSO REQUIRES A VARIANCE REPORT TO OUTLINE THESE DEVIATIONS IN EXPENSES. IN ADDITION, THE ASSOCIATION REQUIRES PROTOCOL CONTINUATION APPROVAL (I.E., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL ETHICAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCOL (rDNA)) ANNUALLY, AS APPLICABLE. ANY SUBSEQUENT PAYMENTS TO GRANT AWARDEES ARE GENERATED AFTER THE RECEIPT OF THESE DOCUMENTS AND IS ULTIMATELY APPROVED BY THE CHIEF SCIENCE OFFICER, MEDICAL AND SCIENTIFIC RELATIONS BEFORE BEING FORWARDED TO FINANCE FOR REVIEW AND PAYMENT. AT THE CONCLUSION OF THE AWARD, ALL REPORTS/PUBLICATION(S) ARE DUE 90 DAYS AFTER THE AWARD EXPIRES AND MUST BE UPLOADED TO THE PROPOSALCENTRAL ONLINE SYSTEM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD. PUBLICATION(S) ARE UPLOADED TO PROPOSALCENTRAL (AFTER BEING ACCEPTED FOR PUBLICATION) DURING AND AFTER THE DURATION OF THE GRANT. IT IS EXPECTED THAT AWARDEES WILL CONTINUE TO MAINTAIN RECORDS OF ANY PUBLICATION(S) ACKNOWLEDGING THE ALZHEIMER'S ASSOCIATION. DATA GENERATED AS A RESULT OF ALZHEIMER'S ASSOCIATION FUNDED WORK IS SUBJECT TO DATA SHARING, AS A CONDITION OF AWARD. DATA AND OTHER OUTPUTS OF THE PROJECT ARE SUBJECTED TO THIS POLICY FOR QUICK, REASONABLE SUBMISSIONS FOR COMPLETED WORK. FURTHER, AWARDEES AGREE TO SUBMIT/SHARE DATA, AS APPLICABLE, THROUGH THE GLOBAL ALZHEIMER'S ASSOCIATION INTERACTIVE NETWORK (GAAIN*), A GLOBAL INFRASTRUCTURE CONNECTING RESEARCH STUDIES FROM AROUND THE WORLD THROUGH ONE PORTAL WHERE DATA CAN BE INTERROGATED IN AGGREGATE FOR ANALYSIS USING A VIRTUAL MACHINE. GAAIN IS WHOLLY FUNDED BY THE ALZHEIMER'S ASSOCIATION. IN ADDITION, THE ASSOCIATION REQUESTS, MONITORS, AND FOLLOWS-UP TO ENSURE SUBMISSION COMPLIANCE ON ALL AWARDED GRANTS AND THAT FINANCIAL REPORTING REQUIREMENTS ARE MET. AWARDEES' FINANCIAL REPORTS ARE REVIEWED ANNUALLY, OR BASED ON THEIR SPECIFIC SCHEDULED REPORTING REQUIREMENTS, TO ENSURE ELIGIBILITY FOR CONTINUED FUNDING. DELINQUENT REPORT(S) MAY RESULT IN THE WITHDRAWAL OF FUNDING. RESEARCHERS ARE INFORMED THAT DELINQUENT REPORTING COULD LEAD TO WITHDRAWAL OF FUNDING WHEN THE REQUEST FOR ANNUAL REPORT(S) IS SENT. IF FUNDING IS WITHDRAWN DUE TO DELINQUENT REPORTS, ANY UNSPENT FUNDS ABOVE $75 USD MUST BE RETURNED TO THE ALZHEIMER'S ASSOCIATION. FOREIGN INSTITUTIONS ARE REQUIRED TO SUBMIT ONE OF THE FOLLOWING AS VERIFICATION OF NON-PROFIT STATUS: - ORGANIZATION'S CHARTER, BYLAWS AND OTHER GOVERNING DOCUMENTS (IN ENGLISH, IF POSSIBLE). IN CASES WHERE TRANSLATION IS NOT POSSIBLE, A DATED AND SIGNED LETTER IN ENGLISH FROM THE RECTOR OR OTHER AUTHORIZED SIGNING OFFICIAL OF THE INSTITUTION IS ACCEPTABLE. - DOCUMENTATION OF NON-PROFIT DESIGNATION FROM ORGANIZATION'S GOVERNMENT. FOR-PROFIT ORGANIZATIONS ARE NOT ELIGIBLE TO APPLY TO THE ALZHEIMER'S ASSOCIATION'S INTERNATIONAL RESEARCH GRANT PROGRAM, WITH THE EXCEPTION OF THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT PROGRAM, ALZHEIMERS INNOVATION AWARD AND CERTAIN PARTNERSHIP PROGRAMS, INCLUDING BUT NOT LIMITED TO BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES (BAND) AND TAU PIPELINE ENABLING PROGRAM (T-PEP). ELIGIBILITY OF ORGANIZATIONS APPLICABLE FOR A PROGRAM ARE DETAILED IN THAT PROGRAM'S RFA. FOR THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT PROGRAM AND OTHER PROGRAMS WITH FOR-PROFIT AWARDEES, ANY FOR-PROFIT APPLICANT IS REQUIRED TO SUBMIT THE ORGANIZATION'S FINANCIAL STATEMENTS. AS PART OF THE APPLICATION PROCESS, APPLICANTS ARE TO UPLOAD A W-9 OR W-8BEN-E FORM THAT HAS BEEN DATED AND SIGNED BY AN AUTHORIZED SIGNING OFFICIAL. THIS FORM VERIFIES THAT AN INSTITUTION OR ORGANIZATION IS DESIGNATED AS A 501(C)(3) OR OTHER NON-PROFIT ENTITY. FOR PROFIT ORGANIZATIONS MUST SUBMIT DOCUMENTATION OF NET ASSETS AND ANNUAL EARNINGS, IN ADDITION TO THE W-9 OR W-8BEN-E FORM FOR CONSIDERATION. THESE FORMS ARE UPLOADED WITHIN THEIR SUBMITTED APPLICATION TO PROPOSALCENTRAL. AFTER RECEIPT, THESE FORMS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER. FOLLOWING REVIEW, APPLICATIONS ARE THEN MOVED FORWARD TO PEER-REVIEW. IF AWARDED, THE ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER INCLUDES THE APPROPRIATE FORMS IN PAYMENT REQUESTS FOR GRANT FUNDING PAYMENTS. PRIOR TO AWARD CONFIRMATION, THE MEDICAL AND SCIENTIFIC RELATIONS DIVISION VERIFIES THAT EACH INSTITUTION IS COMPLIANT WITH THE U.S. PATRIOT ACT AND DOES NOT APPEAR ON THE SPECIALLY DESIGNATED NATIONALS (SDN) LISTS. ADDITIONALLY, PRIOR TO EVERY PAYMENT, EACH FUNDED ALZHEIMERS ASSOCIATION GRANT AWARDEE (I.E. THE INSTITUTION) IS VERIFIED FOR COMPLIANCE WITH THE U.S. PATRIOT ACT. THE GRANT STAFF TEAM MEMBER CONFIRMS ELIGIBILITY AND PROVIDES THIS DOCUMENTATION TO THE GRANT ONLINE FILE AT PROPOSALCENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WILL BE IMMEDIATELY REPORTED TO THE ALZHEIMERS ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. FOR TRANSACTIONS UNRELATED TO THE INTERNATIONAL RESEARCH GRANT PROGRAM IN THE MEDICAL AND SCIENTIFIC DEPARTMENT, THE SAME FINANCIAL DOCUMENTATION IS REVIEWED. THE ALZHEIMER'S ASSOCIATION MONITORS THE SCIENTIFIC ADVANCES OF THE ASSOCIATION'S GRANT AWARDEES BY MAINTAINING RECORDS OF PUBLICATIONS, PRESENTATIONS, AND INTELLECTUAL PROPERTY THAT RESULT FROM FUNDED STUDIES. THE ASSOCIATION REQUIRES THE GRANT RECIPIENT TO NOTIFY THE ALZHEIMER'S ASSOCIATION ON AN ANNUAL BASIS WITH UPDATES TO THESE RECORDS. FOLLOW-ON FUNDING FROM FEDERAL AGENCIES IS ALSO MONITORED. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. Schedule F, Part I, Line 3, Column (f) and Part II, Line 1 Method Used to Account for Expenditures and Grants The Alzheimer's Association accounts for expenditures, cash grants, and noncash assistance using the accrual method. X X X X X X X true THD 80 Hayden Avenue SUIte 300 Lexington MA 02421 MAIL false 40325210 1349333 38975877 CDR 16900 Science Drive SUIte 210 Bowie MD 20715 EMAIL false 24598108 242400 24355708 64923318 1591733 63331585 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY OKLAHOMA GALA 1568710 101500 1467210 7648 1700 78828 NEW YORK GALA 1133179 80200 1052979 291628 6200 2272 16 2567487 387048 2180439 40388 268201 213088 5269376 568748 4700628 48036 561529 298116 2272 909953 3790675 Schedule G, Part I, Line 2B, Box (III) FUNDRAISING CONSULTANT - CONTROL ARRANGEMENT The Alzheimer's association engages Thompson, Habib & Denison INC. (THD) for professional fundraising consultant services. A description of the arrangement is listed below: Direct marketing strategy and program direction; production management; database management; budgeting management; and report management. The Alzheimer's Association engages Creative Direct Response, Inc. (CDR) for professional fundraising digital marketing consultant services. A description of the arrangement is listed below: Digital Marketing strategy and program direction; E-Mail program management; production management; database management; and budgeting management. Schedule G, Part I, Line 2B, Box (VI) FUNDRAISING CONSULTANT - FEE ARRANGEMENT The agreement between Thompson, Habib & Denison (THD) and the Alzheimer's Association is not a percentage-based agreement. THD is paid a fixed fee per month. The Alzheimer's Association exercises control and approval over the content and frequency of all solicitations. The agreement between Creative Direct Response, Inc. (CDR) and the Alzheimer's Association is not a Percentage-Based Agreement. CDR is paid a fixed fee per month. The Alzheimer's Association exercises control and approval. true Alzheimer's Impact Movement 225 North Michigan Ave Chicago IL 60601 271961435 501(C)(4) 6024958 0 PUBLIC POLICY Banner Alzheimer's Foundation 2901 N Central Ave Phoenix AZ 85012 450233470 501(C)(3) 60989 0 PROGRAM SUPPORT Barnard College 3009 Broadway New York NY 10027 131628149 501(C)(3) 25000 0 PROGRAM SUPPORT Bedford VA Research Corporation Inc 200 Springs Road Bedford MA 01730 043512440 501(C)(3) 116532 0 PROGRAM SUPPORT Brigham and Women's Hospital Inc 75 Francis Street Boston MA 02115 042312909 501(C)(3) 138030 0 PROGRAM SUPPORT Brown University 350 Eddy Street Providence RI 02912 050258809 501(C)(3) 174993 0 PROGRAM SUPPORT Brown University 350 Eddy Street Providence RI 02912 050258809 501(C)(3) 749999 0 PROGRAM SUPPORT California Institute of Technology 1200 E California Blvd Pasadena CA 91125 951643307 501(C)(3) 19574 0 PROGRAM SUPPORT Columbia University Medical Center 630 West 168th Street New York NY 10032 135598093 501(C)(3) 175000 0 PROGRAM SUPPORT Columbia University Medical Center 630 West 168th Street New York NY 10032 135598093 501(C)(3) 150000 0 PROGRAM SUPPORT Columbia University Medical Center 630 West 168th Street New York NY 10032 135598093 501(C)(3) 149938 0 PROGRAM SUPPORT Cyclerion Therapeutics Inc 301 Binney Street Cambridge MA 02142 831895370 N/A 2000000 0 PROGRAM SUPPORT Dancers' Group 44 Gough Street San Francisco CA 94103 942879185 501(C)(3) 25000 0 PROGRAM SUPPORT DTx Pharma LLC 3210 Merryfield Row San Diego CA 92121 822009884 N/A 200000 0 PROGRAM SUPPORT Duke University Medical Center 2200 West Main Street Durham NC 27705 560532129 501(C)(3) 200000 0 PROGRAM SUPPORT Eikonizo Therapeutics Inc 700 North Main Street Boston MA 02139 823062283 N/A 200000 0 PROGRAM SUPPORT Emory University 1599 Clifton Road NE Atlanta GA 30322 580566256 501(C)(3) 148395 0 PROGRAM SUPPORT FOUND FOR THE NAT'L INSTITUTE OF HEALTH 11400 Rockville Pike Bethesda MD 20852 521986675 501(C)(3) 200000 0 PROGRAM SUPPORT FOUND FOR THE NAT'L INSTITUTE OF HEALTH 11400 Rockville Pike Bethesda MD 20852 521986675 501(C)(3) 196717 0 PROGRAM SUPPORT GLOBAL BRAIN HEALTH INSTITUTE 675 NR RISING LN San Francisco CA 94158 800466582 501(C)(3) 25000 0 PROGRAM SUPPORT GLOBAL BRAIN HEALTH INSTITUTE 675 NR RISING LN San Francisco CA 94158 800466582 501(C)(3) 25000 0 PROGRAM SUPPORT GLOBAL BRAIN HEALTH INSTITUTE 675 NR RISING LN San Francisco CA 94158 800466582 501(C)(3) 25000 0 PROGRAM SUPPORT GLOBAL BRAIN HEALTH INSTITUTE 675 NR RISING LN San Francisco CA 94158 800466582 501(C)(3) 25000 0 PROGRAM SUPPORT Icahn School of Medicine at Mount Sinai 1 Gustave L Levy Plc New York NY 10029 136171197 501(C)(3) 174998 0 PROGRAM SUPPORT Icahn School of Medicine at Mount Sinai 1 Gustave L Levy Plc New York NY 10029 136171197 501(C)(3) 10000 0 PROGRAM SUPPORT ImmunoBrain Checkpoint Inc 200 E 61st Street 38F New York NY 10065 811652612 N/A 1000000 0 PROGRAM SUPPORT Indiana University 509 E 3rd Street Bloomington IN 47401 356001673 501(C)(3) 138889 0 PROGRAM SUPPORT Johns Hopkins University School of Medicine 733 North Broadway Suite 117 Baltimore MD 21205 520595110 501(C)(3) 174303 0 PROGRAM SUPPORT Johns Hopkins University School of Medicine 733 North Broadway Suite 117 Baltimore MD 21205 520595110 501(C)(3) 450000 0 PROGRAM SUPPORT Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 175000 0 PROGRAM SUPPORT Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 749999 0 PROGRAM SUPPORT Massachusetts Institute of Technology 77 Massachusetts Avenue Cambridge MA 02139 042103594 501(C)(3) 1860539 0 PROGRAM SUPPORT Mayo Clinic 200 First St SW Rochester MN 55905 416011702 501(C)(3) 745836 0 PROGRAM SUPPORT Mayo Clinic Jacksonville 4500 San Pablo Road Jacksonville FL 32224 593337028 501(C)(3) 117582 0 PROGRAM SUPPORT Menorah Park Foundation 27100 Cedar Road Beachwood OH 44122 341778478 501(C)(3) 25000 0 PROGRAM SUPPORT Michigan State University 426 Auditorium Road East Lansing MI 48824 386005984 501(C)(3) 150000 0 PROGRAM SUPPORT New York University School of Medicine One Park Ave 6th FL New York NY 10016 135562308 501(C)(3) 1000000 0 PROGRAM SUPPORT Oregon Health Sciences University 3181 Sam Jackson Pk Rd Portland OR 97239 931176109 501(C)(3) 25000 0 PROGRAM SUPPORT Research Foundation for Mental Hygiene Inc at Ne 1051 Riverside Drive New York NY 10032 141410842 501(C)(3) 1804966 0 PROGRAM SUPPORT Research Foundation of the State University of New 5510 Melville Library Stony Brook NY 11794 141368361 501(C)(3) 174285 0 PROGRAM SUPPORT Rutgers the State University of NJ 100 Struble Road Branchville NJ 07826 226001086 501(C)(3) 147195 0 PROGRAM SUPPORT Rutgers University Foundation 335 George Street New Brunswick NJ 08901 237318742 501(C)(3) 150000 0 PROGRAM SUPPORT SANFORD BURNHAM PREBYS MEDI DISCOVERY Inst 10901 N Torrey Pines Rd La Jolla CA 92037 510197108 501(C)(3) 175000 0 PROGRAM SUPPORT Stanford University 455 BROADWAY Redwood City CA 94063 941156365 501(C)(3) 175000 0 PROGRAM SUPPORT Stanford University 455 BROADWAY Redwood City CA 94063 941156365 501(C)(3) 175000 0 PROGRAM SUPPORT T3D Therapeutics Inc 68 TW Alexander Drive PO Box 13 Research Triangle Park NC 27709 461674269 N/A 740748 0 PROGRAM SUPPORT Temple University 1801 N Broad ST Philadelphia PA 19122 231365971 501(C)(3) 150000 0 PROGRAM SUPPORT The J David Gladstone Institutes 1650 Owens Street San Francisco CA 94158 237203666 501(C)(3) 140000 0 PROGRAM SUPPORT The Regents of the University of California Davis 1850 Research Park Dr Davis CA 95618 946036494 501(C)(3) 175000 0 PROGRAM SUPPORT The Regents of the University of California Davis 1850 Research Park Dr Davis CA 95618 946036494 501(C)(3) 150000 0 PROGRAM SUPPORT The Regents of the University of California Irvin 141 Innovation Suite 250 Irvine CA 92697 952226406 501(C)(3) 175000 0 PROGRAM SUPPORT The Regents of the University of California Irvin 141 Innovation Suite 250 Irvine CA 92697 952226406 501(C)(3) 175000 0 PROGRAM SUPPORT The Regents of the University of California Irvin 141 Innovation Suite 250 Irvine CA 92697 926977600 501(C)(3) 150000 0 PROGRAM SUPPORT The Regents of the University of California Los A 10889 Wilshire Blvd Los Angeles CA 90095 951642394 501(C)(3) 436470 0 PROGRAM SUPPORT The Regents of the University of California San D 9500 Gilman Drive La Jolla CA 92093 956006144 501(C)(3) 175000 0 PROGRAM SUPPORT The Regents of the University of California San D 9500 Gilman Drive La Jolla CA 92093 956006144 501(C)(3) 100000 0 PROGRAM SUPPORT The Regents of the University of California San D 9500 Gilman Drive San Diego CA 92093 956006144 501(C)(3) 496354 0 PROGRAM SUPPORT The Regents of the University of Michigan 3003 S State Street Ann Arbor MI 48109 386006309 501(C)(3) 175000 0 PROGRAM SUPPORT The Regents of the University of Michigan 3003 S State Street Ann Arbor MI 48109 386006309 501(C)(3) 150000 0 PROGRAM SUPPORT The Research Foundation of SUNY 5510 Melville Library Stony Brook NY 11794 141368361 501(C)(3) 1982718 0 PROGRAM SUPPORT The Salk Institute for Biological Studies 10901 N Torrey Pines Rd La Jolla CA 92037 952160097 501(C)(3) 175000 0 PROGRAM SUPPORT The University of Texas at Arlington 701 S Nedderman Drive Arlington TX 76019 756000121 501(C)(3) 150000 0 PROGRAM SUPPORT The University of Texas Health Science Center at S 7703 Floyd Curl Drive San Antonio TX 78229 741586031 501(C)(3) 1998529 0 PROGRAM SUPPORT The University of Texas Health Science Center at S 7703 Floyd Curl Drive San Antonio TX 78229 741586031 501(C)(3) 250000 0 PROGRAM SUPPORT Trustees of Boston University 85 East Newton Street Boston MA 02118 042103547 501(C)(3) 149997 0 PROGRAM SUPPORT Trustees of Boston University 85 East Newton Street Boston MA 02118 042103547 501(C)(3) 150000 0 PROGRAM SUPPORT University of California San Francisco 3333 California St San Francisco CA 94118 946036493 501(C)(3) 175000 0 PROGRAM SUPPORT University of California San Francisco 3333 California St San Francisco CA 94118 946036493 501(C)(3) 174900 0 PROGRAM SUPPORT University of California San Francisco 3333 California St San Francisco CA 94118 946036493 501(C)(3) 150000 0 PROGRAM SUPPORT University of California San Francisco 3333 California St San Francisco CA 94118 946036493 501(C)(3) 150000 0 PROGRAM SUPPORT University of California San Francisco 3333 California St San Francisco CA 94143 946036493 501(C)(3) 53333 0 PROGRAM SUPPORT University of California San Francisco 1855 Folsom Street San Francisco CA 94143 946036493 501(C)(3) 182920 0 PROGRAM SUPPORT University of California San Francisco 3333 California St San Francisco CA 94143 800466582 501(C)(3) 25000 0 PROGRAM SUPPORT University of California Santa Barbara 3227 Cheadle Hall Santa Barbara CA 93106 956006145 501(C)(3) 750000 0 PROGRAM SUPPORT University of Georgia Research Foundation Inc 310 E Campus Rd Athens GA 30602 581353149 501(C)(3) 150000 0 PROGRAM SUPPORT University of Houston 4302 University Drive Houston TX 77204 746001399 501(C)(3) 150000 0 PROGRAM SUPPORT University of Minnesota - Twin Cities 420 Delaware St SE Minneapolis MN 55455 416007513 501(C)(3) 143295 0 PROGRAM SUPPORT University of Oregon 5219 University of Oregon Eugene OR 97403 464727800 501(C)(3) 149997 0 PROGRAM SUPPORT University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 101900 0 PROGRAM SUPPORT University of Puerto Rico at Cayey 205 Antonio R Barcel Ave Cayey PR 00737 660433766 501(C)(3) 149991 0 PROGRAM SUPPORT University of South Carolina 1600 Hampton St Columbia SC 29208 576001153 501(C)(3) 150000 0 PROGRAM SUPPORT University of Southern California 3720 S Flower St Los Angeles CA 90089 951642394 501(C)(3) 1000000 0 PROGRAM SUPPORT University of Southern California 2001 SOTO STREET LOS ANGELES CA 90089 951642394 501(C)(3) 450000 0 PROGRAM SUPPORT University of Utah 75 S 2000 Salt Lake City UT 84112 876000525 501(C)(3) 149995 0 PROGRAM SUPPORT University of Washington 4333 Brooklyn Ave NE Seattle WA 98195 916001537 501(C)(3) 149036 0 PROGRAM SUPPORT University of Wisconsin-Madison 21 N Park St Ste 6401 Madison WI 53715 396006492 501(C)(3) 174999 0 PROGRAM SUPPORT Vaccinex Inc 1895 Mt Hope Avenue Rochester NY 14620 161603202 N/A 750000 0 PROGRAM SUPPORT Wake Forest University Medical Ctr Blvd WinstonSalem NC 27157 223849199 501(C)(3) 2507432 0 PROGRAM SUPPORT Washington University in St Louis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 379953 0 PROGRAM SUPPORT Washington University in St Louis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 65507 0 PROGRAM SUPPORT Washington University in St Louis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 461962 0 PROGRAM SUPPORT Washington University in St Louis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 156000 0 PROGRAM SUPPORT Washington University in St Louis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 200000 0 PROGRAM SUPPORT Washington University in St Louis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 136956 0 PROGRAM SUPPORT Washington University in StLouis One Brookings Dr St Louis MO 63130 430653611 501(C)(3) 174970 0 PROGRAM SUPPORT Weill Cornell Medical College 1300 York Ave New York NY 10065 131623978 501(C)(3) 150000 0 PROGRAM SUPPORT City of Lauderdale Lakes 4320 NW 36th St Fort Lauderdale FL 33319 590974050 501(C)(3) 15000 PROGRAM SUPPORT South Carolina Department of Aging 1301 Gervais St Ste 200 Columbia SC 29201 576000286 501(C)(3) 553598 PROGRAM SUPPORT 91 7 Schedule I, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE THE UNITED STATES. THE OVER-SIGHT OF THE SCIENTIFIC INTEGRITY OF THE ALZHEIMER'S ASSOCIATION NATIONAL AND INTERNATIONAL RESEARCH GRANT PROGRAM IS THREE-FOLD. FIRST, THE ALZHEIMER'S ASSOCIATION VOLUNTARY MEDICAL & SCIENTIFIC ADVISORY GROUP (MSAG), THE ALZHEIMERS ASSOCIATION INTERNATIONAL RESEARCH GRANT PROGRAM COUNCIL (IRGP), AND THE ALZHEIMER'S ASSOCIATION MEDICAL & SCIENTIFIC RELATIONS DIVISION, ENSURES PEER REVIEW AND HIGH QUALITY OF FUNDED AWARDS DURING THE GRANT REVIEW PROCESS AND DEVELOPS FOCUSED REQUESTS FOR APPLICATIONS (RFAS) BASED ON IDENTIFIED NEEDS IN THE ALZHEIMER RESEARCH COMMUNITY. SECOND, THE ALZHEIMER'S ASSOCIATION IS ENGAGED IN A PORTFOLIO ANALYSIS OF SCIENTIFIC AREAS OF INVESTMENT TO MONITOR THE DIVERSITY OF THE GRANTS PORTFOLIO, POTENTIAL GAPS IN RESEARCH FUNDING, AND POTENTIAL OVERLAP OF AREAS FUNDED. THE ANALYSIS INFORMS FUTURE FUNDING DECISIONS, STRATEGIC ACTIVITIES AND AREAS OF FUTURE RFA FOCUS. THIRD, THERE IS A DETAILED PROCESS ONCE A GRANT IS AWARDED TO MONITOR PROGRAM AND SCIENTIFIC AND FINANCIAL INTEGRITY. THE ALZHEIMER'S ASSOCIATION MONITORS THE USE OF GRANT FUNDS BOTH INSIDE AND OUTSIDE OF THE UNITED STATES AS FOLLOWS: ALL AWARDEES ARE REQUIRED TO PROVIDE ANNUAL AND IN SOME CASES BI-ANNUAL OR QUARTERLY REPORTING TO THE ALZHEIMER'S ASSOCIATION ON BOTH THE STATUS OF THE RESEARCH PROJECT AND FINANCIAL EXPENDITURES ASSOCIATED WITH THE AWARD. SEVERAL PROGRAMS ARE LEVERAGED FUNDING OPPORTUNITIES WITH PARTNER ORGANIZATIONS. THESE RESEARCH PROJECTS AND FINANCIAL EXPENDITURE REPORTS ARE SHARED BETWEEN THE PARTNER ORGANIZATIONS(S). SIXTY DAYS PRIOR TO THE ANNIVERSARY OF THE AWARD START DATE, AN ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER NOTIFIES ALL RESEARCHERS AND ALL DESIGNATED INSTITUTIONAL FINANCIAL OFFICIALS WITH FISCAL RESPONSIBILITY FOR THE AWARD OF THE REQUIRED REPORTS, WHICH INCLUDE AN INTERIM SCIENTIFIC REPORT, INTERIM FINANCIAL REPORT, DOCUMENTATION OF ANY PUBLICATIONS AS A RESULT OF ASSOCIATION FUNDING, AND ANNUAL VERIFICATION OF REQUIRED ETHICAL (ANIMAL AND HUMAN) APPROVALS. THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD CANNOT BE THE PRIMARY INVESTIGATOR OF THE PROJECT. THE ALZHEIMER'S ASSOCIATION PROVIDES A TEMPLATE FOR THE INTERIM SCIENTIFIC REPORT AND A TEMPLATE FOR THE INTERIM FINANCIAL REPORT, BOTH OF WHICH ARE AVAILABLE FOR DOWNLOAD BY THE RESEARCHERS AS WELL AS THE OFFICIAL WITH FISCAL RESPONSIBILITY FOR THE GRANT AT THE AWARDED INSTITUTION AT HTTPS://PROPOSALCENTRAL.COM/. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WITH FISCAL RESPONSIBILITY, AND ALL REPORTS MUST BE UPLOADED BY THE AWARD RECIPIENT TO PROPOSALCENTRAL. AFTER RECEIPT, ALL FINANCIAL REPORTS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER FOR ACCURACY AND CONSISTENCY WITH THE AGREED UPON BUDGET. ANY SIGNIFICANT VARIANCE IN EXPENDITURES (MORE THAN 10% DIFFERENCE) TO THE APPROVED BUDGET ALSO REQUIRES A VARIANCE REPORT TO OUTLINE THESE DEVIATIONS IN EXPENSES. IN ADDITION, THE ASSOCIATION REQUIRES PROTOCOL CONTINUATION APPROVAL (I.E., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL ETHICAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCOL (RDNA)) ANNUALLY, IF APPLICABLE FOR THE RESEARCH PROJECT. ANY SUBSEQUENT PAYMENTS TO GRANT AWARDEES ARE GENERATED AFTER THE RECEIPT OF THESE DOCUMENTS AND ULTIMATELY APPROVAL BY THE CHIEF SCIENCE OFFICER, MEDICAL AND SCIENTIFIC RELATIONS TO FORWARD TO FINANCE FOR REVIEW AND PAYMENT. AT THE CONCLUSION OF THE AWARD, ALL REPORTS/PUBLICATION(S) ARE DUE 90 DAYS AFTER THE AWARD EXPIRES AND MUST BE UPLOADED TO THE PROPOSALCENTRAL ONLINE SYSTEM. THE FINANCIAL REPORT MUST BE SIGNED BY THE INSTITUTIONAL OFFICIAL WHO HAS FISCAL RESPONSIBILITY FOR THE AWARD. PUBLICATION(S) ARE UPLOADED TO PROPOSALCENTRAL (AFTER BEING ACCEPTED FOR PUBLICATION) DURING AND AFTER THE DURATION OF THE GRANT. IT IS EXPECTED THAT AWARDEES WILL CONTINUE TO MAINTAIN RECORDS OF ANY PUBLICATION(S) ACKNOWLEDGING THE ALZHEIMER'S ASSOCIATION. DATA GENERATED AS THE RESULT OF ALZHEIMER'S ASSOCIATION FUNDED WORK IS SUBJECT TO DATA SHARING, AS A CONDITION OF AWARD. DATA AND OTHER OUTPUTS OF THE PROJECT ARE SUBJECTED TO THIS POLICY FOR QUICK, REASONABLE SUBMISSIONS FOR COMPLETED WORK. FURTHER, AWARDEES AGREE TO SUBMIT/SHARE DATA, AS APPLICABLE, THROUGH THE GLOBAL ALZHEIMER'S ASSOCIATION INTERACTIVE NETWORK (GAAIN*), A GLOBAL INFRASTRUCTURE CONNECTING RESEARCH STUDIES FROM AROUND THE WORLD THROUGH ONE PORTAL WHERE DATA CAN BE INTERROGATED IN AGGREGATE FOR ANALYSIS USING A VIRTUAL MACHINE. GAAIN IS WHOLLY FUNDED BY THE ALZHEIMER'S ASSOCIATION. IN ADDITION, THE ASSOCIATION REQUESTS, MONITORS, AND FOLLOWS-UP TO ENSURE SUBMISSION COMPLIANCE ON ALL AWARDED GRANTS AND THAT FINANCIAL REPORTING REQUIREMENTS ARE MET. AWARDEES' FINANCIAL REPORTS ARE REVIEWED ANNUALLY TO ENSURE ELIGIBILITY FOR CONTINUED FUNDING. DELINQUENT REPORT(S) MAY RESULT IN THE WITHDRAWAL OF FUNDING. RESEARCHERS ARE INFORMED THAT DELINQUENT REPORTING COULD LEAD TO WITHDRAWAL OF FUNDING WHEN THE REQUEST FOR ANNUAL REPORT(S) IS SENT. IF FUNDING IS WITHDRAWN DUE TO DELINQUENT REPORTS, ANY UNSPENT FUNDS ABOVE USD $75 MUST BE RETURNED TO THE ALZHEIMER'S ASSOCIATION. FOR-PROFIT ORGANIZATIONS ARE NOT ELIGIBLE TO APPLY TO THE ALZHEIMER'S ASSOCIATION'S INTERNATIONAL RESEARCH GRANT PROGRAM, WITH THE EXCEPTION OF REQUESTS FOR APPLICATIONS WHERE OTHERWISE NOTED, SUCH AS THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT, ALZHEIMERS INNOVATION AWARD AND CERTAIN PARTNERSHIP PROGRAMS, INCLUDING BUT NOT LIMITED TO BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES (BAND) AND TAU PIPELINE ENABLING PROGRAM (T-PEP). ELIGIBILITY OF ORGANIZATIONS APPLICABLE FOR A PROGRAM ARE DETAILED IN THAT PROGRAM'S RFA. FOR THE PART THE CLOUD TRANSLATIONAL RESEARCH GRANT PROGRAM AND OTHER PROGRAMS WITH FOR-PROFIT AWARDEES, ANY FOR-PROFIT APPLICANT IS REQUIRED TO SUBMIT THE ORGANIZATION'S FINANCIAL STATEMENTS. AS PART OF THE APPLICATION PROCESS, APPLICANTS ARE REQUIRED TO UPLOAD A W-9 OR W-8BEN-E FORM THAT HAS BEEN DATED AND SIGNED BY AN AUTHORIZED SIGNING OFFICIAL. THIS FORM VERIFIES THAT AN INSTITUTION OR ORGANIZATION IS DESIGNATED AS A 501(C)(3) OR OTHER NON-PROFIT ENTITY. FOR PROFIT ORGANIZATIONS MUST SUBMIT DOCUMENTATION OF NET ASSETS AND ANNUAL EARNINGS, IN ADDITION TO THE W-9 OR W-8BEN-E FORM FOR CONSIDERATION. THESE FORMS ARE UPLOADED WITHIN THEIR SUBMITTED APPLICATION TO PROPOSALCENTRAL. AFTER RECEIPT, THESE FORMS ARE REVIEWED BY AN ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER. FOLLOWING REVIEW BY A GRANT STAFF TEAM MEMBER, APPLICATIONS ARE THEN MOVED FORWARD TO PEER-REVIEW. IF AWARDED, THE ALZHEIMER'S ASSOCIATION GRANT STAFF TEAM MEMBER INCLUDES THE APPROPRIATE FORMS IN PAYMENT REQUESTS FOR GRANT FUNDING PAYMENTS. PRIOR TO AWARD CONFIRMATION, THE MEDICAL AND SCIENTIFIC RELATIONS DIVISION VERIFIES THAT EACH INSTITUTION IS COMPLIANT WITH THE U.S. PATRIOT ACT AND DOES NOT APPEAR ON THE SPECIALLY DESIGNATED NATIONALS (SDN) LISTS. PRIOR TO PAYMENT, EACH FUNDED ALZHEIMERS ASSOCIATION GRANT AWARDEE (I.E. THE INSTITUTION) IS VERIFIED FOR COMPLIANCE WITH THE U.S. PATRIOT ACT. THE GRANT STAFF TEAM MEMBER CONFIRMS ELIGIBILITY AND PROVIDES THIS DOCUMENTATION TO THE GRANT ONLINE FILE AT PROPOSALCENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WOULD IMMEDIATELY BE REPORTED TO THE ALZHEIMERS ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. FOR TRANSACTIONS UNRELATED TO THE INTERNATIONAL RESEARCH GRANT PROGRAM IN THE MEDICAL AND SCIENTIFIC DEPARTMENT, THE SAME FINANCIAL DOCUMENTATION IS REVIEWED. THE ALZHEIMER'S ASSOCIATION MONITORS THE SCIENTIFIC ADVANCES OF THE ASSOCIATION'S GRANT AWARDEES BY MAINTAINING RECORDS OF PUBLICATIONS, PRESENTATIONS, AND INTELLECTUAL PROPERTY THAT RESULT FROM FUNDED STUDIES. THE ASSOCIATION REQUIRES THE GRANT RECIPIENT TO NOTIFY THE ALZHEIMER'S ASSOCIATION ON AN ANNUAL BASIS WITH UPDATES TO THESE RECORDS. FOLLOW-ON FUNDING FROM FEDERAL AGENCIES IS ALSO MONITORED. THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2020 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT - NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. X true true X X X X X false false false false false false false false false HARRY JOHNS President & CEO 791995 5597 188973 0 315430 0 30800 0 25703 0 1352901 5597 0 0 RICHARD HOVLAND COO & ASST. TREAS. 444577 1004 134400 0 3458 0 68300 0 30588 0 681323 1004 0 0 Maria Carrillo Chief Science Officer 405542 0 120375 0 690 0 30800 0 8404 0 565811 0 0 0 ROBERT EGGE CHIEF PUBLIC POLICY OFFICER 377988 19422 120375 0 690 0 30800 0 35185 0 565038 19422 0 0 Donna McCullough Chief Development Officer 358274 2379 106280 0 1365 0 55800 0 11754 0 533473 2379 0 0 KENANN CASSIDY EAST AREA LEADER 358615 0 106875 0 3234 0 30800 0 14659 0 514183 0 0 0 Glenda Berry WEST AREA LEADER 356007 0 106875 0 1980 0 30800 0 22878 0 518540 0 0 0 Christine Foh Asst Secy & VP Legal & GC 229091 0 34438 0 1867 0 29548 0 11590 0 306534 0 0 0 Michelle Helton Chief Financial Officer 216942 0 34124 0 828 0 23845 0 35962 0 311701 0 0 0 Katherine JOANNE PIKE Chief Strategy Officer 315612 0 90750 0 1282 0 30800 0 31491 0 469935 0 0 0 SCHEDULE J, PART I, LINE 1A TRAVEL FOR COMPANIONS AT TIMES A BOARD MEMBER WITH EARLY ONSET ALZHEIMER'S DISEASE MAY REQUIRE A COMPANION TO ACCOMPANY HIM OR HER ON BUSINESS TRAVEL FOR SAFETY REASONS. SINCE HIS OR HER INVOLVEMENT IN THE MEETINGS IS CRITICAL TO REPRESENTING KEY CONSTITUENTS AND APPROPRIATELY FULFILLING THE MISSION OF THE ALZHEIMER'S ASSOCIATION, THE EXPENSES OF COMPANION TRAVEL ARE REIMBURSED. SCHEDULE J, PART I, LINE 4B SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN THERE WERE NO ADDITIONAL AMOUNTS ACCRUED OR REPORTED FOR HARRY JOHNS OR RICHARD HOVLAND RELATED TO A 457(B) PLAN IN CALENDAR YEAR 2019. SCHEDULE J, PART II, COLUMN (B) (II) SUPPLEMENTAL COMPENSATION INFORMATION: BONUS AND INCENTIVE COMPENSATION HARRY JOHNS RECEIVED PERFORMANCE BASED INCENTIVE COMPENSATION OF $188,973 BASED ON HIS SUCCESSFUL ACHIEVEMENT OF SPECIFIC GOALS, WHICH WERE DEVELOPED, REVIEWED, AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS IN CONSULTATION WITH THE BOARD'S INDEPENDENT THIRD-PARTY COMPENSATION CONSULTANTS. THIS PERFORMANCE BASED INCENTIVE COMPENSATION WAS EARNED FOR PERFORMANCE IN FISCAL YEAR 2019 AND WAS PAID IN CALENDAR YEAR 2019. RICHARD HOVLAND, ROBERT EGGE, MARIA CARRILLO, DONNA MCCULLOUGH, GLENDA BERRY, KENANN CASSIDY, CHRISTINE FOH, JOANNE PIKE, AND MICHELLE HELTON RECEIVED PERFORMANCE BASED INCENTIVES EARNED IN FISCAL YEAR 2019 AND PAID IN CALENDAR YEAR 2019. SCHEDULE J, PART II, COLUMN (B) (III) SUPPLEMENTAL COMPENSATION INFORMATION: OTHER REPORTABLE COMPENSATION HARRY JOHNS' OTHER REPORTABLE COMPENSATION INCLUDES A LONG-TERM INCENTIVE RETENTION INCENTIVE ACCRUAL OF $313,450 WHICH WAS PAID IN CALENDAR YEAR 2019 AND WAS TIED TO SPECIFIC MULTI-YEAR VESTING REQUIREMENTS THROUGH JUNE 30, 2019, PAYABLE BEFORE MARCH 15, 2020. HARRY JOHNS AND RICHARD HOVLAND RECEIVE A BASIC LIFE INSURANCE BENEFIT OF ONE TIMES THE ANNUAL SALARY. THE AMOUNT REPRESENTED IN THIS SECTION IS IMPUTED INCOME FOR THE GROUP TERM LIFE BENEFIT. ROBERT EGGE, MARIA CARRILLO, DONNA MCCULLOUGH, GLENDA BERRY, KENANN CASSIDY, CHRISTINE FOH, JOANNE PIKE, AND MICHELLE HELTON ALSO RECEIVE THE LIFE INSURANCE BENEFIT. RICHARD HOVLAND, KENANN CASSIDY, CHRISTINE FOH, AND MICHELLE HELTON HAVE ADDITIONAL IMPUTED INCOME FOR VOLUNTARY ELECTIONS UNDER THE GROUP DISABILITY PLAN. SCHEDULE J, PART II, COLUMN (C) SUPPLEMENTAL COMPENSATION INFORMATION: RETIREMENT AND OTHER DEFERRED COMPENSATION HARRY JOHNS - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED BROAD-BASED 401(K) RETIREMENT PLAN - $30,800. RICHARD HOVLAND - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN - $30,800. DONNA MCCULLOUGH, ROBERT EGGE, MARIA CARRILLO, GLENDA BERRY, KENANN CASSIDY, CHRISTINE FOH, JOANNE PIKE, AND MICHELLE HELTON - RETIREMENT AND OTHER DEFERRED COMPENSATION INCLUDES EMPLOYER CONTRIBUTIONS TO A QUALIFIED 401(K) RETIREMENT PLAN. SCHEDULE J, PART II, COLUMN (D) SUPPLEMENTAL COMPENSATION INFORMATION: NONTAXABLE BENEFITS HARRY JOHNS - NON-TAXABLE BENEFITS OF $25,703 INCLUDE EMPLOYER CONTRIBUTIONS TO MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON HIS PERSONAL ELECTIONS FOR CALENDAR YEAR 2019 THROUGH THE BENEFIT OFFERINGS AVAILABLE TO ALL OTHER BENEFITS-ELIGIBLE EMPLOYEES AT OUR ORGANIZATION. THE AMOUNTS REPRESENTED FOR RICHARD HOVLAND, ROBERT EGGE, MARIA CARRILLO, DONNA MCCULLOUGH, GLENDA BERRY, KENANN CASSIDY, CHRISTINE FOH, JOANNE PIKE, AND MICHELLE HELTON REPRESENT COMPANY CONTRIBUTIONS TO THE MEDICAL, DENTAL, BASIC LIFE INSURANCE, SHORT AND LONG-TERM DISABILITY, AND LONG-TERM CARE INSURANCE BASED ON INDIVIDUAL ELECTIONS. X 387 10976711 FAIR MARKET VALUE X NON GALA-RELATED NONCASH ITEMS 1030 254257 FAIR MARKET VALUE X GALA-RELATED NONCASH ITEMS 54 173217 FAIR MARKET VALUE X MISC. NONCASH ITEMS 2 3215 FAIR MARKET VALUE false true true SCHEDULE M, PART I, LINE 25 AND LINE 32B THIRD PARTY ASSISTANCE OF NONCASH CONTRIBUTIONS LINE 25 - THE ALZHEIMER'S ASSOCIATION RECEIVES VARIOUS NONCASH CONTRIBUTIONS FOR THEIR FUNDRAISING EVENTS. THESE ITEMS INCLUDE SPORTING TICKETS, JEWELRY, CONCERT TICKETS, DINNERS AND VARIOUS OTHER PACKAGES. LINE 32B - A THIRD PARTY RECEIVES DIRECTLY, SELLS AND REMITS PROCEEDS FROM AUTOMOBILE SALES. Schedule M, Part I, Column B Alzheimer's Association is reporting the dollar amount of noncash contributions as well as the number of items received. FORM 990, PART III, LINE 1 ORGANIZATION'S MISSION, CONTINUED THE ALZHEIMER'S ASSOCIATION LEADS THE WAY TO END ALZHEIMER'S AND ALL OTHER DEMENTIA - BY ACCELERATING GLOBAL RESEARCH, DRIVING RISK REDUCTION AND EARLY DETECTION, AND MAXIMIZING QUALITY CARE AND SUPPORT. THE VISION OF THE ALZHEIMER'S ASSOCIATION IS A WORLD WITHOUT ALZHEIMER'S AND ALL OTHER DEMENTIA. THE ALZHEIMER'S ASSOCIATION IS A VALUED RESOURCE FOR CAREGIVERS AND THOSE LIVING WITH THE DISEASE, OFFERING INFORMATION, EDUCATION AND SUPPORT. APPROXIMATELY 262 OFFICES ACROSS THE U.S. ARE DOING BUSINESS AS THE ALZHEIMER'S ASSOCIATION AND VARIOUS NAMES AS A COLLECTION OF 75 CHAPTERS WORKING TO ACCOMPLISH THE MISSION. THE ORGANIZATION IS HEADQUARTERED IN CHICAGO, AND HAS A PUBLIC POLICY OFFICE IN WASHINGTON, D.C. THE ALZHEIMER'S ASSOCIATION PROVIDES 24/7 CONSTITUENT SUPPORT IN OVER 200 LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE 365 DAYS A YEAR (1-800-272-3900) AS WELL AS ON OUR WEBSITE, ALZ.ORG*. AS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN CARE, SUPPORT AND RESEARCH, CURRENTLY, THE ASSOCIATION IS INVESTING OVER $208 MILLION IN 590 ACTIVE BEST-OF-FIELD PROJECTS IN 31 COUNTRIES. AS A LEADER IN THE FIELD, THE ALZHEIMER'S ASSOCIATION FOSTERS COLLABORATION OF THE SCIENTIFIC COMMUNITY BY HOSTING THE LARGEST INTERNATIONAL CONFERENCE FOCUSING ON ALZHEIMER'S DISEASE RESEARCH IN THE WORLD. IN ADDITION, THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS, SPEAKING UP TO HELP ENCOURAGE CONGRESS TO TAKE ACTION IN THE FIGHT AGAINST THIS DISEASE, (INCLUDING THROUGH AN ANNUAL ADVOCACY FORUM IN WASHINGTON, D.C.) AND LEADS ADVOCACY EFFORTS IN EVERY STATE. CONCERN ABOUT ALZHEIMER'S DISEASE AND AWARENESS ABOUT THE ASSOCIATION ARE CRITICAL TO ACCELERATING PROGRESS. THE ALZHEIMER'S ASSOCIATION STRIVES TO MAKE MORE PEOPLE AWARE OF THE SERVICES AVAILABLE FOR THOSE FACING THIS DISEASE AND THE BENEFITS OF EARLY DETECTION. (MORE THAN 5 MILLION ALZHEIMER'S ASSOCIATION CONSTITUENTS HAVE SIGNED UP TO EDUCATE, ADVOCATE, DONATE, AND PARTICIPATE TO MOVE THIS CAUSE FORWARD). A DONOR-SUPPORTED ORGANIZATION, THE ALZHEIMER'S ASSOCIATION ALLOCATES ITS FUNDS IN AN ETHICAL AND RESPONSIBLE MANNER THAT EXCEEDS THE RIGOROUS STANDARDS OF AMERICA'S MOST EXPERIENCED CHARITY EVALUATOR, THE BETTER BUSINESS BUREAU WISE GIVING ALLIANCE. THE ASSOCIATION IS QUALIFIED TO USE THE "BBB TORCH LOGOA NATIONAL CHARITY SEAL ("SEAL"). * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART III, LINE 4D OTHER PROGRAM SERVICES ADVOCACY - AS ALZHEIMER'S DISEASE THREATENS TO BANKRUPT FAMILIES, BUSINESSES AND OUR HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF RISK REDUCTION AND ULTIMATELY A CURE, AS WELL AS FOR BETTER CARE AND RESOURCES, AND HEALTH AND LONG-TERM COVERAGE TO ENSURE HIGH QUALITY COST EFFECTIVE CARE FOR PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR FAMILIES. MORE THAN 600,000 GRASS ROOTS ALZHEIMER'S ASSOCIATION ADVOCATES SPEAK UP FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND ENCOURAGE CONGRESS TO INCREASE FUNDING FOR RESEARCH AND CARE. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. CARE, SUPPORT AND RISK REDUCTION - THE ALZHEIMER'S ASSOCIATION* PROVIDES AN ARRAY OF INFORMATION AND SUPPORT SERVICES DESIGNED SPECIFICALLY FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES, FRIENDS AND CAREGIVERS. IN ORDER TO MEET THE DIVERSE NEEDS OF INDIVIDUALS AFFECTED BY ALZHEIMER'S DISEASE, THE ASSOCIATION'S PROGRAMS AND SERVICES ARE OFFERED IN PERSON, BY PHONE AND ONLINE. IN CHAPTERS THROUGHOUT THE COUNTRY, CONSTITUENTS CAN ATTEND EDUCATION PROGRAMS AND SUPPORT GROUPS, RECEIVE PERSONALIZED CARE CONSULTATION, ENGAGE IN EARLY STAGE PROGRAMS, AND ENROLL IN SUPPORT PROGRAMS. IN ORDER TO MEET THE NEEDS OF CONSTITUENTS WHO RELY ON THE WEB FOR INFORMATION AND SUPPORT, THE ASSOCIATION OFFERS A ROBUST CAREGIVER CENTER. WITHIN THE CAREGIVER CENTER, FAMILIES AND CAREGIVERS CAN ACCESS ALZHEIMER'S NAVIGATOR*, AN INNOVATIVE TOOL TO HELP CAREGIVERS AND PEOPLE WITH DEMENTIA EVALUATE THEIR NEEDS, CREATE A CUSTOMIZED ACTION PLAN AND LINK TO INFORMATION, SUPPORT AND LOCAL RESOURCES FOR INDIVIDUALS LIVING WITH ALZHEIMER'S. ALSO AVAILABLE THROUGH THE CAREGIVER CENTER, FOR INDIVIDUALS LOOKING FOR SUPPORT FROM OTHERS LIVING IN SIMILAR SITUATIONS IS ALZCONNECTED*, AN ON-LINE COMMUNITY THAT INCLUDES MULTIPLE FORUMS FOR DIVERSE AUDIENCES. THROUGH THE ASSOCIATION'S HELPLINE, AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK, 365 DAYS A YEAR, INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES AND CAREGIVERS CAN TALK TO A SPECIALIST TO RECEIVE INFORMATION AND BASIC EDUCATION ABOUT THE DISEASE; AND GUIDANCE FOR MORE COMPLICATED OR URGENT SITUATIONS, WITH MASTERS-LEVEL COUNSELORS WHO ARE AVAILABLE TO CONSTITUENTS, ANY TIME, DAY OR NIGHT. ADDITIONALLY, CALLS CAN BE HANDLED IN OVER 200 DIFFERENT LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE. ANNUALLY, THE HELPLINE RECEIVES APPROXIMATELY 275,000 CALLS. THE ASSOCIATION'S WEBSITE (WWW.ALZ.ORG*) RECEIVES MORE THAN 21 MILLION VISITS A YEAR. ONLINE PROGRAMS INCLUDE: SELF-SERVICE EDUCATION PROGRAMS, AN ONLINE COMMUNITY, AN INTERACTIVE BRAIN TOUR (AVAILABLE IN 15 LANGUAGES), ACCESS TO COMPREHENSIVE DISEASE INFORMATION, PORTALS IN SPANISH, CHINESE, VIETNAMESE, JAPANESE, AND KOREAN; A VIRTUAL LIBRARY, A SAFETY CENTER, AND A SECTION DEVELOPED SPECIFICALLY FOR PEOPLE LIVING WITH ALZHEIMER'S, WITH INPUT FROM PEOPLE IN THE EARLY STAGES OF ALZHEIMER'S DISEASE AND THEIR CARE PARTNERS. IN ADDITION, LIVE CHAT WITH THE HELPLINE TEAM IS AVAILABLE THROUGH THE WEBSITE. THROUGH THE ASSOCIATION'S EARLY STAGE INITIATIVE, INDIVIDUALS IN THE EARLY STAGES OF THE DISEASE CAN PARTICIPATE IN EDUCATION PROGRAMS, SUPPORT GROUPS AND SOCIAL ENGAGEMENT PROGRAMS. ADDITIONALLY, THE ASSOCIATION CONVENES AN EARLY STAGE ADVISORY GROUP WHOSE MEMBERS RAISE AWARENESS, ADVOCATE FOR THE CAUSE, AND PROVIDE GUIDANCE AND REVIEW OF PROGRAMS AND SERVICES. THE ALZHEIMER'S ASSOCIATION HAS LAUNCHED AN INITIATIVE TO WORK WITH HEALTH SYSTEMS, LONG-TERM CARE FACILITIES, AND COMMUNITY-BASED DEMENTIA PROVIDERS WITH EVIDENCE-BASED INFORMATION AND QUALITY IMPROVEMENT PROGRAMMING TO ENHANCE HOW THESE SYSTEMS PROVIDE CARE AND SUPPORT SERVICES. UNIQUE PROGRAMMING OPPORTUNITIES INCLUDE DIRECT TRAINING TO PROVIDERS AND VIDEO-BASED EDUCATION THROUGH PROJECT ECHO. THE PROGRAMS AND SERVICES OF THE ALZHEIMER'S ASSOCIATION ARE DESIGNED TO PROVIDE EDUCATION, INFORMATION, SUPPORT, AND RESOURCES IN ORDER TO HELP INDIVIDUALS WITH ALZHEIMER's, THEIR FAMILIES AND CAREGIVERS NAVIGATE THE LONG AND COMPLICATED JOURNEY THROUGH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS. * THESE ARE NAMES THAT ARE TRADEMARKS TO ALZHEIMER'S ASSOCIATION. FORM 990, PART VI, LINE 1A GOVERNING BODY: THE BOARD OF DIRECTORS OF THE ALZHEIMERS ASSOCIATION IS THE ORGANIZATION'S GOVERNING BODY. THE BOARD HAS DELEGATED AUTHORITY TO ITS STANDING AND OTHER BUSINESS COMMITTEES AS DESCRIBED IN ARTICLE VII OF THE ORGANIZATIONAL BYLAWS. THE FOLLOWING EXCERPT FROM THE ASSOCIATION'S BYLAWS DISCUSS COMMITTEES OF THE BOARD OF DIRECTORS. COMMITTEES OF DIRECTORS: ALL COMMITTEE MEETINGS SHALL BE OPEN TO ATTENDANCE BY ALL DIRECTORS EXCEPT IN EXECUTIVE SESSION. ONLY COMMITTEE MEMBERS MAY VOTE ON COMMITTEE MATTERS. THE BOARD OF DIRECTORS SHALL HAVE THE FOLLOWING STANDING COMMITTEES: EXECUTIVE, FINANCE, GOVERNANCE AND NOMINATING, COMPENSATION, AUDIT AND MISSION OUTCOMES. EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL MANAGE THE BUSINESS AND PROPERTY OF THE ASSOCIATION IN BETWEEN MEETINGS OF THE BOARD OF DIRECTORS; PROVIDED, THAT THE EXECUTIVE COMMITTEE SHALL NOT TAKE ANY ACTION WHICH IS CONTRARY TO POLICIES OF THE ASSOCIATION AS ADOPTED BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL HAVE SUCH ADDITIONAL POWERS AS MAY BE PROVIDED BY LAW OR RESOLUTION OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL REPORT TO THE BOARD OF DIRECTORS AT EACH MEETING OF THE BOARD OF DIRECTORS AND REPORT EXECUTIVE COMMITTEE ACTIONS IN A TIMELY MANNER IN BETWEEN BOARD OF DIRECTORS MEETINGS. AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT AN EXECUTIVE COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN DIRECTORS. THE CHAIR, CHAIR ELECT, VICE CHAIRS, SECRETARY, TREASURER, CHAIRS OF THE STANDING COMMITTEES, AND THE CHAIR OF THE MEDICAL AND SCIENTIFIC ADVISORY GROUP, SHALL BE MEMBERS OF THE EXECUTIVE COMMITTEE. THE CHAIR OF THE BOARD OF DIRECTORS SHALL BE THE CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE MAY HOLD REGULAR MEETINGS MONTHLY OR AS IT MAY OTHERWISE DETERMINE, AT SUCH PLACE AND AT SUCH TIMES AND UPON SUCH NOTICE AS IT MAY DETERMINE. SPECIAL MEETINGS OF THE EXECUTIVE COMMITTEE MAY BE CALLED AT ANY TIME BY THE CHAIR OR BY ANY THREE OF ITS MEMBERS, BY NOTICE DELIVERED PERSONALLY OR BY MAIL, TELEPHONE, ELECTRONIC MAIL OR FACSIMILE AT LEAST SEVEN DAYS (OR AT LEAST 48 HOURS IN THE CASE OF TELEPHONIC MEETINGS) PRIOR TO THE MEETING. A MAJORITY OF THE CURRENTLY SERVING MEMBERS OF THE EXECUTIVE COMMITTEE SHALL CONSTITUTE A QUORUM FOR ALL PURPOSES. FINANCE COMMITTEE: THE FINANCE COMMITTEE SHALL CONSIST OF AT LEAST FIVE DIRECTORS AND SHALL BE CHAIRED BY THE TREASURER. THE FINANCE COMMITTEE SHALL OVERSEE AND REVIEW ALL FINANCIAL REPORTS, ACCOUNTING ACTIVITIES AND INVESTMENT DECISIONS OF THE ASSOCIATION AND ALSO SHALL PREPARE A PROJECTED BUDGET FOR EACH FISCAL YEAR TO BE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL. THE FINANCE COMMITTEE SHALL OVERSEE AND MAKE RECOMMENDATIONS TO THE BOARD OF DIRECTORS WITH RESPECT TO THE FINANCIAL OPERATION OF ALZHEIMERS ASSOCIATION 401(K) SAVINGS PLAN AND THE APPOINTMENT OF FIDUCIARIES WITH RESPECT THERETO. GOVERNANCE AND NOMINATING COMMITTEE: AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT A GOVERNANCE AND NOMINATING COMMITTEE CONSISTING OF NO FEWER THAN SEVEN NOR MORE THAN FIFTEEN INDIVIDUALS CURRENTLY SERVING AS A DIRECTOR. AT LEAST ONE-THIRD OF THE GOVERNANCE AND NOMINATING COMMITTEE SHALL BE DIRECTORS HAVING CHAPTER EXPERIENCE. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL ASSIST THE BOARD IN ENSURING THE SUCCESSFUL GOVERNANCE OF THE ASSOCIATION THROUGH BOARD ASSESSMENT, RECRUITMENT, NOMINATIONS, ORIENTATION AND DEVELOPMENT. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL NOMINATE CANDIDATES FOR DIRECTORS, OFFICERS AND MEMBERS OF THE EXECUTIVE COMMITTEE. THE GOVERNANCE AND NOMINATING COMMITTEE MAY NOMINATE CANDIDATES FOR HONORARY DIRECTOR AND ANY ADVISORY OR HONORARY COUNCILS, GROUPS OR COMMITTEES AND APPROVE THE CANDIDATES FOR MEDICAL AND SCIENTIFIC ADVISORY GROUP MEMBERSHIP. THE GOVERNANCE AND NOMINATING COMMITTEE ALSO SHALL PROVIDE INPUT TO THE CHAIR ON THE SELECTION OF VICE CHAIRS AND COMMITTEE CHAIRS. COMPENSATION COMMITTEE: THE COMPENSATION COMMITTEE SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING, SUBJECT TO FURTHER AND FINAL APPROVAL BY THE BOARD OF DIRECTORS, ALL FORMS OF COMPENSATION AND BENEFITS FOR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE COMPENSATION COMMITTEE SHALL CONDUCT ITS REVIEW AND APPROVAL OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICERS TOTAL COMPENSATION AND BENEFITS IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED ("SECTION 4958"). THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR REVIEWING AND APPROVING APPROPRIATE MARKET DATA, TO BE USED BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER TO SET OR ADJUST COMPENSATION OF ANY OTHER EXECUTIVE-LEVEL EMPLOYEE WHO COULD BE CONSIDERED TO BE IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER THE AFFAIRS OF THE ASSOCIATION WITHIN THE MEANING OF SECTION 4958. THE COMPENSATION COMMITTEE ALSO SHALL BE RESPONSIBLE FOR OVERSIGHT OF EXECUTIVE-LEVEL BENEFITS AND SUCCESSION PLANNING FOR KEY POSITIONS IN THE ASSOCIATION. AUDIT COMMITTEE: THE AUDIT COMMITTEE SHALL BE RESPONSIBLE FOR RECOMMENDING AN AUDITOR TO THE BOARD OF DIRECTORS AND SHALL OVERSEE THE ACTIVITIES OF ANY INTERNAL AUDITOR OF THE ASSOCIATION. THE AUDIT COMMITTEE SHALL SEE THAT AN ANNUAL AUDIT IS PREPARED BY AN INDEPENDENT FIRM OF CERTIFIED PUBLIC ACCOUNTANTS SELECTED BY THE BOARD OF DIRECTORS AND, UPON RECEIVING SUCH AUDITOR'S REPORT, THE AUDIT COMMITTEE SHALL PREVIEW THE AUDIT REPORT FOR SUBMISSION TO THE BOARD OF DIRECTORS EACH YEAR. THE AUDIT COMMITTEE SHALL REVIEW THE FINANCIAL REPORTS OF THE ASSOCIATION, ITS SYSTEM OF INTERNAL CONTROLS, AND THE AUDIT PROCESS. THE AUDIT COMMITTEE SHALL HAVE AT LEAST FIVE MEMBERS, ALL OF WHOM ARE MEMBERS OF THE BOARD OF DIRECTORS AND THE MAJORITY OF WHOM HAVE APPROPRIATE FINANCIAL EXPERTISE. AT LEAST ONE MEMBER OF THE AUDIT COMMITTEE SHALL MEET THE REQUIREMENT OF "AUDIT COMMITTEE FINANCIAL EXPERT" AS THEN DEFINED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MAJORITY OF THE MEMBERS OF THE AUDIT COMMITTEE MAY NOT CONCURRENTLY SERVE ON THE FINANCE COMMITTEE AND THE TREASURER AND CHAIR OF THE FINANCE COMMITTEE MAY NOT SERVE CONCURRENTLY ON THE AUDIT COMMITTEE. MISSION OUTCOMES COMMITTEE: THE MISSION OUTCOMES COMMITTEE SHALL OVERSEE AND REVIEW PROGRESS AGAINST THE ALZHEIMERS ASSOCIATIONS STRATEGIC PLANS PRIORITY ACTIVITIES AND SHALL SUPPORT AND FACILITATE BOARD OF DIRECTORS CONVERSATIONS THAT ARE FOCUSED ON MISSION DELIVERY AND THE APPROVED STRATEGIC PLAN. OTHER COMMITTEES: IN ADDITION TO THE STANDING COMMITTEES, OTHER COMMITTEES MAY BE DESIGNATED BY RESOLUTION ADOPTED BY A MAJORITY OF THE DIRECTORS PRESENT AT ANY MEETING. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE ORGANIZATION UNDERGOES A THOROUGH REVIEW PROCESS BEFORE FILING THE RETURN. THE AUDIT COMMITTEE DISCUSSES AND REVIEWS THE FORM BEFORE IT IS PROVIDED TO THE OFFICERS AND FULL BOARD OF DIRECTORS. ALL OFFICERS AND THE FULL BOARD OF DIRECTORS ARE PROVIDED A COPY FOR THEIR REVIEW AND HAVE THE OPPORTUNITY TO COMMENT BEFORE THE FORM 990 IS FILED. FORM 990, PART VI, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT THE ALZHEIMER'S ASSOCIATION CONFLICT OF INTEREST POLICY IS DESCRIBED IN ARTICLE XII, SECTION 2 OF THE ORGANIZATIONAL BYLAWS. THE RESPONSIBILITY FOR DISCLOSING ANY KNOWN OR REASONABLY FORESEEABLE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST SHALL BE DISCLOSED TO THE BOARD OF DIRECTORS OR ITS COMMITTEE DESIGNEE BY THE INTERESTED PERSON WHOSE INTERESTS ARE OR MAY APPEAR TO BE IN CONFLICT WITH THE ASSOCIATION. ALL INTERESTED PERSONS ARE REQUIRED TO FILE WITH THE ASSOCIATION A DISCLOSURE STATEMENT PRIOR TO SUCH INDIVIDUAL COMMENCING HIS OR HER SERVICE WITH THE ASSOCIATION AND AT SUCH TIME AND IN SUCH MANNER AS MAY BE PROVIDED IN GUIDELINES ADOPTED BY THE BOARD OF DIRECTORS. ALL INTERESTED PERSONS SERVING THE ASSOCIATION SHALL FILE DISCLOSURE STATEMENTS, FROM TIME TO TIME, AS MAY BE REQUIRED BY THE BOARD OF DIRECTORS, THE BYLAWS ARTICLE XII, SECTION 2 OR ANY OTHER BOARD POLICY, AND IN NO EVENT LESS OFTEN THAN ANNUALLY. INTERESTED PERSONS SHALL DISCLOSE ANY CONFLICT AND SHALL NOT VOTE ON A MATTER AND FURTHER IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. THE MINUTES SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THE INTERESTED PERSON DID NOT PARTICIPATE IN ANY DISCUSSION OF THE MATTER AND DID NOT VOTE ON THE MATTER IN PERSON OR BY PROXY. WHEN ANY SUCH CONFLICT OF INTEREST IS RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD OF DIRECTORS OR ANY COMMITTEE OF THE BOARD, THE INTERESTED PERSON SHALL DISCLOSE SUCH CONFLICT TO THE BOARD OF DIRECTORS OR SUCH COMMITTEE AND SHALL NOT VOTE ON THE MATTER. FURTHER THE INTERESTED PERSON OR REPRESENTATIVE HAVING A CONFLICT IF REQUESTED BY THE CHAIR OR RESOLUTION OF THE BOARD SHALL LEAVE THE ROOM IN WHICH THE BOARD OR THE COMMITTEE IS MEETING AND SHALL NOT PARTICIPATE IN ANY DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY A VOTE OF THE BOARD OF DIRECTORS OR THE COMMITTEE, AS THE CASE MAY BE, EXCLUDING THE INTERESTED PERSON CONCERNING WHOM THE DOUBT HAS ARISEN. COPIES OF THE ASSOCIATION BYLAWS ARTICLE, INCLUDING THE CONFLICT OF INTEREST POLICY AND ANY RELATED ETHICAL POLICY OR GUIDELINES AS FROM TIME TO TIME ADOPTED OR AMENDED BY THE BOARD OF DIRECTORS, SHALL BE PRESENTED TO ALL INTERESTED PERSONS SERVING THE ASSOCIATION AT THE TIME OF ANY SUCH ADOPTION OR AMENDMENT AND IN NO EVENT LESS OFTEN THAN ANNUALLY; AND TO ALL INDIVIDUALS SEEKING TO SERVE THE ASSOCIATION AS AN INTERESTED PERSON PRIOR TO REQUESTING ANY SUCH INDIVIDUAL TO EXECUTE A CONFLICT OF INTEREST DISCLOSURE STATEMENT. FORM 990, PART VI, LINES 15A & 15B PROCESS FOR DETERMINING COMPENSATION COMPENSATION IS ESTABLISHED FOR THE CEO BY THE COMPENSATION COMMITTEE AND THE EXECUTIVE COMMITTEE AFTER A THOROUGH SALARY/MARKET REVIEW CONDUCTED BY OUTSIDE COMPENSATION CONSULTANTS. FOR THE CEO POSITION, THE GATHERING OF RELEVANT COMPARABILITY DATA FROM INDEPENDENT SOURCES OCCURRED IN 2019. THE PROCESS WAS CONDUCTED IN A MANNER INTENDED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER THE INTERMEDIATE SANCTIONS RULES. AS TO THE MEMBERS OF THE SENIOR MANAGEMENT TEAM OTHER THAN THE CEO, ANNUALLY UPDATED MARKET DATA IS ALSO PROVIDED BY THE OUTSIDE COMPENSATION CONSULTANT, SO THAT THE UPDATED MARKET DATA CAN BE USED IN SETTING REASONABLE COMPENSATION FOR EACH MEMBER OF THE SENIOR MANAGEMENT TEAM. EACH YEAR THE COMPENSATION COMMITTEE EVALUATES THE CEO'S PERFORMANCE THROUGH A ROBUST ASSESSMENT PROCESS WHICH INCLUDES COLLECTION, INTERVIEWS AND PERFORMANCE EVALUATION COMPARING RESULTS TO GOALS. THE COMMITTEE AND CHAIR OF THE BOARD USE THIS DATA TO DETERMINE INCENTIVE COMPENSATION ELIGIBILITY. THE SENIOR STAFF HAS A COMPREHENSIVE PERFORMANCE EVALUATION AND COMPENSATION REVIEW DONE AT THE END OF EACH FISCAL YEAR. THESE INCLUDE A SELF-ASSESSMENT AND EVALUATION BY THE CEO. UPDATED MARKET DATA FOR USE IN SETTING REASONABLE COMPENSATION IS PROVIDED BY A NATIONAL COMPENSATION CONSULTING FIRM TO THE COMPENSATION COMMITTEE FOR CONFIRMATION OF REASONABLENESS USING A PROCESS DESIGNED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS (INCLUDING CONTEMPORANEOUS DOCUMENTATION IN THE COMMITTEE'S MINUTES). FOR FISCAL YEAR 2020, THE SALARY AND TOTAL COMPENSATION PACKAGE OF THE CEO WAS BENCHMARKED BY SULLIVAN COTTER. COMPENSATION IS CONTEMPORANEOUSLY DOCUMENTED IN THE COMPENSATION COMMITTEE MINUTES. FORM 990, PART VI, LINE 18 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION MAKES ITS FORM 990 AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS FORM 1023 AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART VI, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC BY POSTING ON THE ORGANIZATION'S WEBSITE AT WWW.ALZ.ORG AND UPON REQUEST. THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9 OTHER CHANGE IN NET ASSETS OR FUND BALANCE CHANGE IN PERPETUAL TRUST $(514,280) CHANGE IN SPLIT INTEREST $(542,513) BAD DEBT EXPENSE $(4,538,460) ------------ TOTAL $(5,595,253) General Note EFFECTIVE JULY 1, 2016, ONE CHAPTER DISSOLVED AND 46 CHAPTERS MERGED WITH THE ASSOCIATION TO CREATE A UNITED ALZHEIMERS ASSOCIATION. TOTAL ASSETS ACQUIRED FROM THE 47 CHAPTERS WERE APPROXIMATELY $152,004,000 AND NET ASSETS ACQUIRED WERE APPROXIMATELY $130,859,000. THE ASSOCIATION OVERSEES THE OPERATIONS AND ACTIVITIES FOR 75 CHAPTERS TO FACILITATE STRATEGIC ALIGNMENT, DELIVER ON THE OVERARCHING ASSOCIATION-WIDE STRATEGIC OBJECTIVES AND PRIORITY ACTIVITIES, AND TO ENSURE COVERAGE FOR ALL GEOGRAPHIC TERRITORIES. Alzheimer's Impact Movement (AIM) 225 N Michigan Ave Fl 17 Chicago IL 60601 271961435 SOC Welfare IL 501(C)(4) Alz Assoc true Alzheimer's Association International 181 Bay St Brookfield Pl 2100 Toronto Ontario CA M5J2T3 999999999 PUBLIC FDN CA 501(C)(3) Alz Assoc true Coalition of NY State Alz Assn Chaps Inc 4 Pine West Plaza 405 Albany NY 12205 134076596 Public Char NY 501(c)(3) Alz Assoc true false true false false false false false false false false false false true true false false false false Alzheimer's Impact Movement B 6024958 FMV Alzheimer's Impact Movement N 308978 FMV Alzheimer's Impact Movement O 3790549 FMV Coalition of NY State Alz Assn Chaps Inc O 57674 FMV Schedule R, Part V, Line 2 AMOUNT INVOLVED IN RELATIONSHIP THE ALZHEIMER'S ASSOCIATION GRANTED FUNDS TO ALZHEIMER'S IMPACT MOVEMENT (AIM) FOR PUBLIC POLICY DIVISION ACTIVITIES IN FISCAL YEAR 2020 TO SUPPORT PRIORITIES IDENTIFIED IN THE ALZHEIMER'S ASSOCIATION'S STRATEGIC PLAN. THIS GRANT IS RESTRICTED TO THE FOLLOWING 501(C)(3) ACTIVITIES AND THE ANCILLARY ACTIVITIES NECESSARY TO ACCOMPLISH SPECIFIC GOALS INCLUDING: IMPLEMENTATION OF THE NATIONAL ALZHEIMER'S PROJECT ACT (RECOGNIZING THIS GROWING ALZHEIMER'S CRISIS, CONGRESS UNANIMOUSLY PASSED AND THE PRESIDENT SIGNED INTO LAW THE NATIONAL ALZHEIMER'S PROJECT ACT - NAPA); INCREASING THE COMMITMENT TO ALZHEIMER'S RESEARCH; EXPANDING EDUCATION EFFORTS AND CAREGIVER SUPPORT SERVICES; EXPANDING DIAGNOSIS AND PLANNING.